Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

A Kinase Inhibitor with Anti-Pim Kinase Activity is a Potent and Selective Cytotoxic Agent Toward Acute Myeloid Leukemia.

Bjørnstad R, Aesoy R, Bruserud Ø, Brenner AK, Giraud F, Dowling TH, Gausdal G, Moreau P, Døskeland SO, Anizon F, Herfindal L.

Mol Cancer Ther. 2019 Mar;18(3):567-578. doi: 10.1158/1535-7163.MCT-17-1234. Epub 2019 Jan 24.

PMID:
30679386
2.

Deletion of exchange proteins directly activated by cAMP (Epac) causes defects in hippocampal signaling in female mice.

Aesoy R, Muwonge H, Asrud KS, Sabir M, Witsoe SL, Bjornstad R, Kopperud RK, Hoivik EA, Doskeland SO, Bakke M.

PLoS One. 2018 Jul 26;13(7):e0200935. doi: 10.1371/journal.pone.0200935. eCollection 2018.

3.

Total synthesis and antileukemic evaluations of the phenazine 5,10-dioxide natural products iodinin, myxin and their derivatives.

Viktorsson EÖ, Melling Grøthe B, Aesoy R, Sabir M, Snellingen S, Prandina A, Høgmoen Åstrand OA, Bonge-Hansen T, Døskeland SO, Herfindal L, Rongved P.

Bioorg Med Chem. 2017 Apr 1;25(7):2285-2293. doi: 10.1016/j.bmc.2017.02.058. Epub 2017 Feb 28.

PMID:
28284865
4.

Long-term consumption of an obesogenic high fat diet prior to ischemia-reperfusion mediates cardioprotection via Epac1-dependent signaling.

Edland F, Wergeland A, Kopperud R, Åsrud KS, Hoivik EA, Witsø SL, Æsøy R, Madsen L, Kristiansen K, Bakke M, Døskeland SO, Jonassen AK.

Nutr Metab (Lond). 2016 Nov 28;13:87. eCollection 2016.

5.

Role of EPAC in cAMP-Mediated Actions in Adrenocortical Cells.

Lewis AE, Aesoy R, Bakke M.

Front Endocrinol (Lausanne). 2016 Jun 13;7:63. doi: 10.3389/fendo.2016.00063. eCollection 2016. Review.

6.

Insights into Orphan Nuclear Receptors as Prognostic Markers and Novel Therapeutic Targets for Breast Cancer.

Aesoy R, Clyne CD, Chand AL.

Front Endocrinol (Lausanne). 2015 Aug 7;6:115. doi: 10.3389/fendo.2015.00115. eCollection 2015. Review.

7.

Regulation of CDKN2B expression by interaction of Arnt with Miz-1--a basis for functional integration between the HIF and Myc gene regulatory pathways.

Aesoy R, Gradin K, Aasrud KS, Hoivik EA, Ruas JL, Poellinger L, Bakke M.

Mol Cancer. 2014 Mar 11;13:54. doi: 10.1186/1476-4598-13-54.

8.

The alkylating prodrug J1 can be activated by aminopeptidase N, leading to a possible target directed release of melphalan.

Wickström M, Viktorsson K, Lundholm L, Aesoy R, Nygren H, Sooman L, Fryknäs M, Vogel LK, Lewensohn R, Larsson R, Gullbo J.

Biochem Pharmacol. 2010 May 1;79(9):1281-90. doi: 10.1016/j.bcp.2009.12.022. Epub 2010 Jan 11.

PMID:
20067771
9.

An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.

Aesoy R, Sanchez BC, Norum JH, Lewensohn R, Viktorsson K, Linderholm B.

Mol Cancer Res. 2008 Oct;6(10):1630-8. doi: 10.1158/1541-7786.MCR-07-2172.

10.

Deoxyribonucleic acid methylation controls cell type-specific expression of steroidogenic factor 1.

Hoivik EA, Aumo L, Aesoy R, Lillefosse H, Lewis AE, Perrett RM, Stallings NR, Hanley NA, Bakke M.

Endocrinology. 2008 Nov;149(11):5599-609. doi: 10.1210/en.2008-0104. Epub 2008 Jul 24.

PMID:
18653709
11.

Differential regulation of SF-1-cofactor interactions.

Lund J, Børud B, Mellgren G, Aesøy R, Hoang T, Jacob AL, Bakke M.

Endocr Res. 2002 Nov;28(4):505-13. Review.

PMID:
12530655
12.

Activation of cAMP-dependent protein kinase increases the protein level of steroidogenic factor-1.

Aesøy R, Mellgren G, Morohashi K, Lund J.

Endocrinology. 2002 Jan;143(1):295-303.

PMID:
11751621
13.

Biochemical and functional analysis of nuclear receptors as targets in cAMP-dependent control of bovine CYP17.

Lund J, Jacob A, Aesöy R, Yri OE, Mellgren G.

Endocr Res. 1998 Aug-Nov;24(3-4):497-504.

PMID:
9888530

Supplemental Content

Support Center